Size-Dependent Attenuation of TLR9 Signaling by Gold Nanoparticles in Macrophages

Gold nanoparticles (GNPs), which are generally thought to be bio-inert and non-cytotoxic, have become one of the most ideal nanomaterials for medical applications. Once engulfed by phagocytes, the immunological effects of GNPs are still of concern and require detailed investigation. Therefore, this study explored the immunological significance of GNPs on TLR-mediated innate immunity in murine macrophages. GNP causes specific inhibition of TLR9 (CpG oligodeoxynucleotides; CpG-ODNs) signal in macrophages. The impaired CpG-ODN–induced TNF-α production is GNP concentration- and size-dependent in murine Raw264.7 cells: a GNP of 4 nm in size is more potent than a GNP of 11, 19, 35, or 45 nm in size. Consistent with cytokine inhibition, the CpG-ODN–induced phosphorylation of NF-κB and JNK as well as NF-κB activation are suppressed by GNPs. GNPs accumulate in lysosomes after phagocytosis and also increase TLR9-associated lysosomal cathepsin expression and activities, but this is irrelevant to TLR9 inhibition by GNPs in our studies. In addition, GNPs affected TLR9 translocation in response to CpG-ODNs and to phagosomes. Further exploring how GNPs inhibited TLR9 function, we found that GNPs could bind to high-mobility group box-1 (which is involved in the regulation of TLR9 signaling) inside the lysosomes. The current studies demonstrate that size-dependent inhibition of TLR9 function by GNP may be attributed to its binding to high-mobility group box-1.

[1]  Haichao Wang,et al.  A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. , 2007, Blood.

[2]  R. Shukla,et al.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[3]  Shaojun Dong,et al.  Effect of colloidal gold size on the conformational changes of adsorbed cytochrome c: probing by circular dichroism, UV-visible, and infrared spectroscopy. , 2005, Biomacromolecules.

[4]  Jin Hong,et al.  Size-dependent tissue kinetics of PEG-coated gold nanoparticles. , 2010, Toxicology and applied pharmacology.

[5]  K. Miyake,et al.  Cathepsins are required for Toll-like receptor 9 responses. , 2008, Biochemical and biophysical research communications.

[6]  Håkan Wallin,et al.  Protracted elimination of gold nanoparticles from mouse liver. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[7]  D. Pozo,et al.  Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands. , 2008, Nanomedicine.

[8]  Chao-Liang Wu,et al.  Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. , 2007, Molecular pharmaceutics.

[9]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[10]  K. Ishii,et al.  Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. , 2004, Seminars in immunology.

[11]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[12]  B. Monks,et al.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.

[13]  Y. Yoshioka,et al.  Titanium dioxide induces different levels of IL-1beta production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B. , 2010, Biochemical and biophysical research communications.

[14]  S. Akira,et al.  HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses , 2009, Nature.

[15]  Steven A. Curley,et al.  Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles , 2010, Clinical Cancer Research.

[16]  D. Astruc,et al.  Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.

[17]  A. Iwasaki,et al.  Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.

[18]  S. Akira,et al.  Pathogen recognition in the innate immune response. , 2009, The Biochemical journal.

[19]  P. Alivisatos The use of nanocrystals in biological detection , 2004, Nature Biotechnology.

[20]  Moonjung Choi,et al.  Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. , 2010, ACS nano.

[21]  H. Rauvala,et al.  30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. , 1991, The Journal of biological chemistry.

[22]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[23]  David Leong,et al.  Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. , 2007, Molecular pharmaceutics.

[24]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[25]  T. Guilarte,et al.  Silica-Based Nanoparticle Uptake and Cellular Response by Primary Microglia , 2009, Environmental health perspectives.

[26]  H. Ploegh,et al.  Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9 , 2008, Nature Immunology.

[27]  Helinor J Johnston,et al.  A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity , 2010, Critical reviews in toxicology.

[28]  Priyabrata Mukherjee,et al.  Biological properties of "naked" metal nanoparticles. , 2008, Advanced drug delivery reviews.

[29]  Andrew E. Parker,et al.  Targeting Toll-like receptors: emerging therapeutics? , 2010, Nature Reviews Drug Discovery.

[30]  C. Leifer,et al.  TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA , 2008, Immunology and cell biology.

[31]  S. Maschalidi,et al.  Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. , 2009, Immunity.

[32]  Jürgen Groll,et al.  Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. , 2010, ACS nano.

[33]  L. Audoly,et al.  Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.

[34]  Hoguen Kim,et al.  Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function. , 2010, Journal of proteome research.

[35]  Elodie Boisselier,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[36]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[37]  A. Barrios,et al.  Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I). , 2004, Bioorganic & medicinal chemistry letters.

[38]  Soo-Ki Kim,et al.  Dependence on p38 MAPK signalling in the up‐regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis‐treated HeLa cells , 2006, Immunology.

[39]  Dar-Bin Shieh,et al.  A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity , 2004 .

[40]  Chao-Liang Wu,et al.  Amelioration of collagen-induced arthritis in rats by nanogold. , 2007, Arthritis and rheumatism.

[41]  Ling Wang,et al.  Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.

[42]  S. Akira,et al.  Toll‐like receptor expression in murine DC subsets: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines , 2003, European journal of immunology.

[43]  M. Kretzler,et al.  Activation of toll‐like receptor‐9 induces progression of renal disease in MRL‐Fas(lpr) mice , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  M. James,et al.  Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S , 2007, Biological chemistry.

[45]  K. Hua,et al.  Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression. , 2010, Journal of agricultural and food chemistry.

[46]  Håkan Wallin,et al.  Kupffer cells are central in the removal of nanoparticles from the organism , 2007, Particle and Fibre Toxicology.

[47]  G. Frens Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions , 1973 .

[48]  B. Monks,et al.  Ligand-induced conformational changes allosterically activate Toll-like receptor 9 , 2007, Nature Immunology.

[49]  Siamon Gordon,et al.  Pattern Recognition Receptors Doubling Up for the Innate Immune Response , 2002, Cell.

[50]  Diana Boraschi,et al.  Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. , 2004, European cytokine network.

[51]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[52]  Sarah E. Ewald,et al.  The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor , 2008, Nature.

[53]  Ji-Ho Park,et al.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. , 2009, Biomaterials.

[54]  O. Schmid,et al.  Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. , 2010, Toxicology and applied pharmacology.